Clinical trial
The Effect of ALKS 5461 on QT Intervals in Healthy Volunteers
NCT02479308 is registered in ClinicalTrials.gov with Alkermes, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of ALKS 5461 on QT Intervals in Healthy Volunteers
- Lead sponsor
- Alkermes, Inc.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- June 30, 2015
- Completion date
- October 31, 2015
- Enrollment
- 129 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
healthy